Literature DB >> 1747002

A reappraisal of the causes of hemoptysis.

S Santiago1, J Tobias, A J Williams.   

Abstract

We reviewed the records of 264 patients who underwent fiberoptic bronchoscopy for unexplained hemoptysis to determine the various causes of hemoptysis. Bronchogenic carcinoma (29%), bronchitis (23%), and idiopathic hemoptysis (22%) accounted for the majority of causes of hemoptysis. In contrast to older studies, the incidence of hemoptysis secondary to tuberculosis and bronchiectasis has decreased. Although our patient population is predominantly male and elderly, our data may well be representative of more recent epidemiologic trends in causes of hemoptysis.

Entities:  

Mesh：

Year:  1991        PMID： 1747002

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


  10 in total

Review 1.  The pulmonary physician in critical care * Illustrative case 7: Assessment and management of massive haemoptysis.

Authors:  J L Lordan; A Gascoigne; P A Corris
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

2.  Bronchoscopic findings and bleeding control predict survival in patients with solid malignancies presenting with mild hemoptysis.

Authors:  Horiana B Grosu; Roberto F Casal; Rodolfo C Morice; Graciela M Nogueras-González; Georgie A Eapen; David Ost; Mona G Sarkiss; Carlos A Jimenez
Journal:  Ann Am Thorac Soc       Date:  2013-08

3.  Lessons from patients with hemoptysis attending a chest clinic in India.

Authors:  Rajendra Prasad; Rajiv Garg; Sanjay Singhal; Piyush Srivastava
Journal:  Ann Thorac Med       Date:  2009-01       Impact factor: 2.219

4.  Inhaled Tranexamic Acid for Non-Massive Haemoptysis in a Rivaroxaban-Receiving Patient Not Responding to the Oral Form.

Authors:  Mugahid Eltahir; Mohamed Nabil Elshafei; Abdelnasser Elzouki
Journal:  Eur J Case Rep Intern Med       Date:  2020-12-30

5.  Analysis of patients with hemoptysis in a tertiary referral hospital.

Authors:  Bo Ram Lee; Jin Yeong Yu; Hee Jung Ban; In Jae Oh; Kyu Sik Kim; Yong Soo Kwon; Yu Il Kim; Young Chul Kim; Sung Chul Lim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-08-31

Review 6.  Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts.

Authors:  M Reck; F Barlesi; L Crinò; C I Henschke; D Isla; S Stiebeler; D R Spigel
Journal:  Ann Oncol       Date:  2011-11-04       Impact factor: 32.976

7.  Risk of cancer in patients with epistaxis and haemoptysis.

Authors:  Anne G Ording; Katalin Veres; Dóra K Farkas; Kasper Adelborg; Henrik T Sørensen
Journal:  Br J Cancer       Date:  2018-02-20       Impact factor: 7.640

8.  Alarm symptoms and identification of non-cancer diagnoses in primary care: cohort study.

Authors:  Roger Jones; Judith Charlton; Radoslav Latinovic; Martin C Gulliford
Journal:  BMJ       Date:  2009-08-13

9.  Bronchial artery embolization in life-threatening massive hemoptysis.

Authors:  Hossein Ghanaati; Ali Shakouri Rad; Kavous Firouznia; Amir Hossein Jalali
Journal:  Iran Red Crescent Med J       Date:  2013-12-05       Impact factor: 0.611

10.  Efficacy, safety and usability of bronchial artery embolization using a new anti-reflux microcatheter in the management of haemoptysis.

Authors:  Salvatore Alessio Angileri; Giovanni Maria Rodà; Antonio Arrichiello; Giulia Signorelli; Letizia Di Meglio; Martina Gurgitano; Francesco Di Bartolomeo; Anna Maria Ierardi; Aldo Paolucci; Gianpaolo Carrafiello
Journal:  Acta Biomed       Date:  2020-09-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.